Pdfletter to Batavia on Protecting Detained People During COVID-19

Home , Women in medicine

125 Broad Street Vi ct ori a R o e c k Ne w York, N Y 10004 St aff Att or n e y 212.607.3300 vroeck @nyclu.org 212.607.3318 2 1 2 -6 0 7 -3 3 6 8 w w w.nyclu.org A C L U of N e w Y or k Marc h 1 7 , 2 0 2 0 VI A E m ail Tho mas Feeley Jeffre y Searls Dir e ct or A cti n g A d mi nistr at or B uff al o Fi el d Offi c e B uff al o F e d er al D et e nti o n F a cilit y Buffalo. Outreach @ice.dhs.gov Jeffrey.J. Searls @ice.dhs.gov

R e: I nstit uti o n al Pl a n f or Pr e v e nt ati v e M e as ur es A g ai nst C O VI D -1 9

D e ar Mr. F e el e y a n d Mr. S e arls:

As or g a ni z ati o ns t h at r e pr es e nt d et ai n e d i n di vi d u als h el d at t h e B uff al o F e d er al D et e nti o n F a cilit y i n B at a vi a, N e w Y or k ( “ B at a vi a ”), w e writ e to urge you i m m e di at el y t o r el e as e i n di vi d u als w h o ar e at hi g h ris k of contracting C O VI D -1 9 a n d t h os e w h o p os e a l o w ris k of fli g ht a n d d a n g er i n or d er t o li mit e x p os ur e t o t h e vir us a m o n g d et ai n e d p ers o ns, f a cilit y st aff, and the surrounding co m munity . F or t h os e w h o r e m ai n d et ai n e d t hr o u g h o ut t his p a n d e mi c, w e as k t h at y o u d e v el o p a n d i m pl e m e nt pr o a cti v e pl a ns f or t h e pr e v e nti o n and manage ment of t h e vir us at B at a vi a a n d i nf or m t h e d et ai n e d p o p ul ati o n a n d t h e undersigned organizations of t h es e pl a ns b y Fri d a y, M ar c h 2 0 . We have revie wed I C E’s national guidelines and i d e ntifi e d criti c al gaps in the agency’s response. Therefore, we propose additional reco m mendations, developed in c o ns ult ati o n wit h Dr. J ai mi e M e yer, M. D., M. S., F. A. C. P., a pr of ess or at Y al e U ni v ersit y a n d e x p ert i n i nf e cti o us dis e as e i n j ails a n d pris o ns . W e a p pr e ci at e y o ur att e nti o n t o t his ur g e nt m att er. T h e f ail ur e t o h a v e a p pr o pri at e s af e g u ar ds i n pl a c e n o w m a y c ost p e o pl e’s li v es l at er.

As you are certainly a ware, C O VI D -19 poses a serious safet y risk for staff and people i n c ar c er at e d at B at a vi a t h at c o ul d j e o p ar di z e t h e st a n d ar d of c ar e at t h e f a cilit y. I n c ar c er at e d people are particularly vulnerable to outbreaks of contagious diseases. They are housed in close q u art ers, h a v e littl e c o ntr ol o v er t h eir d ail y i nt er a cti o n wit h ot h ers, ar e oft e n i n p o or h e alt h, a n d lack access to necessary cleaning and other supplies. 1 A c c or di n g t o e x p erts o n p u bli c h e alt h i n j ails, “it is o nl y a m att er of ti m e ” b ef or e C O VI D -19 appears in prisons, and “[a] ll pris o ns a n d j ails s h o ul d a nti ci p at e t h at t h e c or o n a vir us will e n t er t h eir f a cilit y . ” 2

1 Saint Louis University, “‘ Ticking Ti me Bo mb’: Prisons Unprepared for Flu Pande mic, Says N e w R es e ar c h. ” S ci e n c e D ail y ( S e pt. 1 5, 2 0 0 6), a v ail a bl e at https:// w w w.sciencedaily.co m/releases/2006/09/060915012301.ht m ; Dr. H o m er V e nt ers, “ 4 w a ys t o pr ot e ct o ur j ails a n d pris o ns fr o m c or o n a vir us. ” T h e Hill ( F e b. 2 9, 2 0 2 0), a v ail a bl e at htt ps://t h e hill -c o m. c d n. a m p pr oj e ct. or g/ c/s/t h e hill. c o m/ o pi ni o n/ cri mi n al -justice/485236 -4 -wa ys - t o -pr ot e ct -o ur -j ails -a n d -pris o ns -fro m -coronavirus?a mp . 2 Ni c ol e W ets m a n, “ Pris o ns a n d j ails ar e v ul n er a bl e t o C O VI D -19 outbreaks,” The Verge ( Mar. 7, 2 0 2 0), a v ail a bl e at https:// w w w.theverge.co m/2020/3/7/21167807/coronavirus -pris o n -j ail -

First, in light of the extre me risks of detention d uring a pande mic, we ask that you i m mediately revie w custody deter minations with the goal of reducing the detained population as much as possible . Public health experts expressly hav e r e c o m m e n d e d t h at i n response to the threat of C O VI D -1 9, j ails s h o ul d “ a v oi d h ol di n g p e o pl e f or l o w -level offenses ” a n d “[ p] e o pl e w h o ar e n’t a ris k t o p u bli c s af et y s h o ul d n’t b e h el d i n a j ail . ” 3 I C E has broad dis cr eti o n t o r el e as e p e o pl e o n b o n d or, if i n eli gi bl e f or b o n d, o n p ar ol e f or “ ur g e nt h u m a nit ari a n r e as o ns or “si g nifi c a nt p u bli c b e n efit .” 4 Here, C O VI D -19 presents an urgent hu manitarian reason f or I C E pr o a cti v el y t o r el e as e p e o pl e o n bond or p ar ol e w h o ar e at hi g h ris k of s eri o us ill n ess if t h e y ar e i nf e ct e d. 5 A c c or di n g t o t h e C e nt er s f or Dis e as e C o ntr ol, t h e hi g h -ris k c at e g or y i n cl u d es ol d er a d ults a n d i n di vi d u als wit h s eri o us c hr o ni c m e di c al c o n diti o ns li k e h e art dis e as e, di a b et es, or l u n g dis e as e. 6 I n a d diti o n, I C E s h o ul d r el e as e — ei t h er o n p ar ol e, o n a lo wer b o n d, or o n a n alt er n ati v e c o n diti o n of r el e as e, s u c h as G P S m o nit ori n g — individuals for who m the agency or an i m mi gr ati o n j u d g e h as s et b o n d, a n d w h o r e m ai n i n y o ur c ust o d y s ol el y d u e t o a n i n a bilit y t o p a y t h at b o n d. I n t h es e c a s es, a n i m mi gr ati o n c o urt or I C E offi ci al h as alr e a d y f o u n d t h at s u c h i n di vi d u als d o n ot p os e a d a n g er t o t h e c o m m u nit y or a si g nifi c a nt fli g ht ris k. 7 R e d u ci n g t h e n u m b er of p e o pl e h el d u n n e c ess aril y at B at a vi a will d e cr e as e h e alt h ris ks n ot o nl y f or t h os e d et ai n e d b ut t h e st aff a n d s urr o u n di n g c o m m u nit y, as w ell.

S e c o n d, for those who re main in detention, we ask that you develo p a m ore d et ail e d plan to prevent C O VI D -19 exposure at Batavia and co m municate that plan to the detained population and the undersigned organizations . T o t h e e xt e nt y o u h a v e n ot d o n e s o alread y , w e ur g e y o u t o w or k t o g et h er wit h p u bli c h e alt h pr of essi o n als , i n cl u di n g t h os e at t h e N e w Y or k St at e a n d Genesee C o u nt y D e p art m e nts of P u bli c H e alt h, t o cr e at e s p e cifi c evidence -b as e d pl a ns to prevent an outbreak of C O VI D -1 9 at B at a vi a. W e h a v e r e as o n t o b eli e v e t h at as of Fri d a y, M ar c h 1 3, f a cilit y l e a d ers hi p h a d n ot c o m m u ni c at e d a n y B at a vi a -s p e cifi c pl a ns t o t h e p e o pl e i n t h eir c ust o d y. W e have revie wed I C E’s March 1 5 n ati o n al g ui d eli n es, 8 b ut t h e y f ail t o a d dr ess several points of concern for our organizations and our expert, Dr. Meyer . T h us, w e as k t h at t h e f a cilit y d e v el o p pl a ns t h at a d dr ess t h e f oll o wi n g p oi nts :

h e alt h -outbreak -c o vi d -1 9 -fl u -s oap ( q u oti n g a n d citi n g Dr. T yl er Wi n k el m a n, c o -dir e ct or of t h e H e alt h, H o m e l ess n ess, a n d Cri mi n al J usti c e La b at t h e H e n n e pi n H e alt h c ar e R es e ar c h I nstit ut e i n Mi n n e a p olis). 3 S e e i d . 4 8 U. S. C. § 1226 ( a); 8 C. F . R. § 2 1 2. 5( b). 5 S e e 8 C. F . R. § 2 1 2. 5( b) (providing for discretionary release of people with “serious medical c o n diti o ns in which continued detention would not be appropriate” and pregnant wo men). 6 S e e C e nt er s for Disease Control and Prevention, “ People at Risk for Serious Illness fro m C O VI D -1 9 ” ( M ar. 1 2, 2 0 2 0), a v ail a bl e at https:// w w w.cdc.gov/coronavirus/2019 -ncov/specif i c - groups/high -ris k -c o m pli c ati o ns. ht ml # w h o -is -hi g h er -ris k . 7 S e e 8 C. F. R. § 2 1 2. 5( b) ( n oti n g p ar ol e of c ert ai n i n di vi d u als is j ustifi e d “ pr o vi d e d t h e ali e ns present neither a security risk nor a risk of absconding”). 8 S e e I m migration and Custo ms Enforce ment, I C E guidance on C O VI D -1 9 ( M ar. 1 5, 2 0 2 0), a v ail a bl e at htt ps:// w w w.i c e. g o v/ c o vi d 1 9 # w c m -survey -t ar g et -i d .

 S a niti z ati o n: W e as k t h at t h e f a cilit y pr o vi d e e xtr a h a n d w as hi n g a n d s a niti zi n g s u p pli es t o st aff , d et ai n e d i n di vi d u als, a n d visit ors, a n d s a niti z e co m mon areas aft er us e.

 Scree ni ng: T h e I C E n ati o n al g ui d eli n es st at e t h at n e w l y d et ai n e d persons will b e s c r e e n e d o n i nt a k e b ut d o n ot st at e t h e pl a ns f or screening staff and others who may be e nt eri n g a n d e xiti n g t h e f a cilit y.

 Isolatio n: T h e I C E n ati o n al g ui d eli n es st at e t h at i n di vi d u als wit h f e v er a n d/ or r es pir at or y s y m pt o ms will b e pl a c e d i n si n gl e m e di c al h o usi n g r o o ms or air b or n e i nf e cti o n is ol ati o n r o o ms, b ut it is u n cl e ar h o w m a n y s u c h r o o ms e xist at B at a vi a. It is als o u n cl e ar w h et h er t h e f a cilit y pl a ns t o t est d et ai n e d i n di vi d u als or st aff f or C O VI D -1 9 , a n d, if s o, h o w a n d w h e n t h os e t ests will b e m a d e a v ail a bl e.

 Ho usi ng: We have reason to believe several double -b u n k e d u nits wit hi n t h e f a cilit y ar e c urr e ntl y at c a p a cit y, p arti c ul arl y t h os e wit h hi g h er s e c urit y cl assifi c ati o ns. W e w o ul d li k e t o k n o w if B at a vi a h as a pl a n t o r e d u c e t h e p o p ul ati o n i n t h e s e u nits a n d/ or r e m o v e hi g h -ris k i n di vi d u als fr o m u nits at or n e ar c a p a cit y t o f a cilit at e s o ci al dist a n ci n g.

 E d ucatio n: W e as k t h at d et ai n e d p e o pl e b e e d u c at e d o n t h e vir us a n d pr e v e nti o n measures they can take as s o o n as pr a cti c a bl e, as w ell as pl a ns f or e d u c ati o n of st aff a n d ot h ers i n r e g ul ar c o nt a ct wit h t h e f a cilit y. E n cl os e d is a p o w er p oi nt pr es e nt ati o n developed by Dr. Anne Spaulding for incarcerated people and correctional staff that m a y b e of us e .

 St affi n g: W e w o ul d li k e t o k n o w t h e pl a ns f or st affi n g t h e f a cilit y if l ar g e n u m b ers of st aff, i n cl u di n g m e di c al st aff, s e c urit y st aff, a n d detained workers involved in food pr e p ar ati o n a n d cl e a ni n g, b e c o m e ill.

 Fl u Vacci nes: The C O VI D -19 pande mic overlaps wit h t h e i n fl u e nza s e as o n, a n d d et ai n e d i n di vi d u als ar e p arti c ul arl y at ris k of c o ntr a cti n g b ot h vir us es at t h e s a m e ti m e. Gi v e n t h at B at a vi a r e c e ntl y s uff er e d a fl u o ut br e a k, w e w o ul d li k e t o k n o w if B at a vi a pl a ns t o pr o vi d e t h e s e as o n al i n fl u e nza v a c ci n e t o all d et ai n e d p ers o ns ( or if y o u h a v e alread y done so).

 Visit ati o n : Gi v e n t h at s o ci al visits ar e suspended a n d l e g al visits ar e r estri ct e d, w e as k t h e f a cilit y t o c o nsi d er pr o vi di n g fr e e a c c ess t o vi d e o or t el e p h o n e c alls f or l e g al a n d s o ci al purpose s.

H a vi n g r o b ust, d et ail e d pl a ns t h at r e d u c e t h e j ail p o p ul ati o n a n d address the above questions can pr e v e nt t h e n e e d f or dr asti c r estri cti o ns l at er o n. We t heref ore as k t h at y o u ( 1) i m m e di at el y r e vi e w c ust o d y d et er mi n ati o ns t o i d e ntif y t h os e eli gi bl e t o be released under affordable b o n ds, alt er n ati v e t o d et e nti o n pr o gr a ms , or p ar ol e ; ( 2) d e v el o p B at a vi a -s p e cifi c pl a ns to address o ur concerns ; a n d ( 3) infor m detained persons and the undersigned organizations of t h es e pl a ns b y Friday, March 20 .

Si n c er el y,

/s/ Vi ct ori a R o e c k Vi ct ori a R o e c k M e g a n S all o mi St aff Att or n e y s

Christopher Dunn L e g al Dir e ct or

T h e N e w Y or k Ci vil Li b erti es U ni o n F o u n d ati o n

/s/ Jilli a n N o w a k Jilli a n N o w a k Supervising I m migration Attorney

Ni c h ol as P hilli ps A p p ell at e Att or n e y

Ji m Millst ei n Managing Attorney

Karen Murtagh E x e c uti v e Dir e ct or

Prisoners’ Legal Services of Ne w York

C C ( vi a e -m ail): A d a m K h alil ; D a ni el M o ar ; D a vi d C ori ell ; U. S. Att or n e y’s Offi c e f or t h e W est er n Distri ct of N e w Y or k

E n cl os ur es: C. V. of Dr. J ai mi e M e yer, M. D., M. S., F. A. C. P. P o w er p oi nt – Coronavirus C O VI D -1 9 a n d t h e C orr e cti o n al F a cilit y b y Dr. A n n e S p a ul di n g

J ai mi e M e y er, M D, M S, F A C P

C URRIC UL U M VITAE

D at e of R e visi o n: Nove mber 20, 2019 N a m e: J ai mi e M e y er, M D, M S, F A C P Sc h o ol: Y al e Sc h o ol of M e dici n e

Ed ucation: BA, Dart mouth College Anthropology 2000 M D, University of Connecticut School of Medicine 2005 MS, Yale School of Public Health Biostatistics and Epide miology 2014

Career/Acade mic Appoint ments: 2 0 0 5 - 2008 Residency, Internal Medicine, NY Presbyterian H os pit al at C ol u m bi a, N e w Y or k, N Y 2 0 0 8 - 2011 Fello wship, Infectious Diseases, Yale University School of Medicine, Ne w Haven, CT 2 0 0 8 - 2012 Cli nic al F ell o w, I nf ecti o us Dis e as es, Y al e Sc h o ol of M e dici n e, N e w H a v e n, C T 2 0 1 0 - 2012 F ell o ws hi p, I nt er disci plinary HI V Prevention, Center for Interdisciplinary Research on AI D S, N e w H a v e n, C T 2 0 1 2 - 2014 Instructor, AI DS, Yale School of Medicine, Ne w Haven, CT 2 0 1 4 - prese nt Assistant Professor, AI DS, Yale School of Medicine, Ne w Haven, CT 2 0 1 5 - 2018 Assist a nt Cli nic al Pr of ess or, N ursi n g, Y al e Sc h o ol of M e dici n e, N e w H a v e n, C T

B oar d Certificati o n: A B of I nt er n al M e dici n e, I nt er n al M e dici n e, 0 8 -2 0 0 8, 0 1 -2019 A B of I nt er n al M e dici n e, I nf ecti o us Dis e as e, 1 0 -2010 AB of Preventive Medicine, Addiction Medicine, 01 -2018

Professional Honors & Recognition: International/ National/Regional 2018 NI H Center for Scientific Revie w, Selected as Early Career Revie wer 2 0 1 7 Doris Duke Charitable Foundation, Doris Duke Charitable Foundation Scholar 2016 A m eric a n C oll e g e of P h ysici a ns, F ell o w 2016 NI H Health Disparities, Loan Repay ment A ward Co mpetitive Rene wal 2016 AA MC, Early Career Wo men Faculty Professional Develop men t S e mi n ar 2014 NI H Health Disparities, Loan Repay ment Progra m A ward 2014 NI D A, Wo men & Sex/ Gender Differences Junior Investigator Travel A ward 2014 International Wo men's/Children's Health & Gender Working Group, Travel A ward 2014 Patterson Trust, A wards Progra m in Clinical Research 2013 Connecticut Infectious Disease Society, Thornton A ward for Clinical Research 2011 Brist ol Myers -S q ui b b, Vir o logy Fello ws A ward

1 J ai mi e M e y er, M D, M S, F A C P

2006 NY Colu mbia Presbyterian, John N. Loeb Intern A ward 2005 A merican Medical Wo men’s Association, Medical Student Citation 2005 Connecticut State Medical Society, Medical Student A ward 2000 Dart mouth College, Hannah Croasdale Senio r A ward 2000 Dart mouth College, Palaeopitus Senior Leadership Society Inductee

Y al e U niv ersit y 2014 Wo men’s Faculty Foru m, Public Voices Thought Leadership Progra m Fello w

Gr a nts/ Cli nic al Tri als Hist or y: Current Grants Age ncy: Center for Interdisciplinary Research on AI DS (CI R A) I. D. #: 2019 -20 Pilot Project A wards Titl e: O pti mizi n g Pr E P’s P ot e nti al i n N o n -Cli nic al S etti n gs: D e v el o p m e nt a n d Evaluation of a PrEP Decision Aid for Wo men Seeking Do mestic Violence S ervic es P.I.: Ti ar a Willi e R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 2 % Direct c osts per year: $29,993.00 T otal c osts f or pr oject p eri o d: $29,993.00 Pr oj ect p eri o d: 7/11/2019 - 7/10/2020

Age ncy: SA MHSA I. D. #: H79 TI080561 Titl e: C HA N GE: Co mprehensive Housing and Addiction Manage ment Net work for Greater Ne w Haven R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 2 0 % Direct c osts per year: $389,054.00 T otal c osts f or pr oject p eri o d: $1,933,368.00 Pr oj ect p eri o d: 11/30/2018 - 11/29/2023

Age ncy: Gil e a d Sci e nc es, I nc. I. D. #: Investigator Sponsored A ward, C O -U S -2 7 6 -D136 Titl e: D eli v eri n g HI V Pr e -Exposure Prophylaxis to Net works of Justice -I n v ol v e d Wo men R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 8 % Direct c osts per year: $81,151.00 T otal c osts f or pr oject

2 J ai mi e M e y er, M D, M S, F A C P p eri o d: $306,199.00 Pr oj ect p eri o d: 6/19/2018 - 1/31/2020

Age ncy: NI D A I. D. #: R21 DA042702 Titl e: Prisons, Drug Injection and the HI V Risk Environ ment R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 2 2 % Direct c osts per year: $129,673.00 T otal c osts f or pr oject p eri o d: $358,276.00 Pr oj ect p eri o d: 8/1/2017 - 7/31/2020

Age ncy: Doris Duke Charitable Foundation I. D. #: Clinical Scientist Develop ment A ward Titl e: Developing and Testin g t he Effect of a Patie nt -Centered HI V Prevention Decision Aid on PrEP uptake for Wo men with Substance Use in Treat ment S etti ngs R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 2 7 % Direct c osts per year: $149,959.00 T otal c osts f or pr oject p eri o d: $493,965.00 Pr oj ect p eri o d: 7/1/2017 - 6/30/2020

Past Gra nts Age ncy: NI D A I. D. #: K23 DA033858 Titl e: Evaluating and I mproving HIV Outco mes in Co m munity -based Wo men who Interface with the Cri minal Justice Syste m R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 7 5 % Direct c osts per year: $149,509.00 T otal c osts f or pr oject p eri o d: $821,147.00 Pr oj ect p eri o d: 7/1/2012 - 11/30/2017

Age ncy: Robert Leet & Clara Guthrie Patterson Trust I. D. #: R12225, A ward in Clinical Research Titl e: Disentangling the Effect of Gender on HI V Treat ment and Cri minal Justice Outco mes R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 1 0 % Direct c osts per ye ar: $75,000.00

3 J ai mi e M e y er, M D, M S, F A C P

T otal c osts f or pr oject p eri o d: $75,000.00 Pr oj ect p eri o d: 1/31/2014 - 10/31/2015

Age ncy: Brist ol -Myers Squibb I. D. #: HI V Vir ol o g y F ell o ws hi p A w ar d Titl e: Effect of ne wer antiretroviral regi mens on HI V biological outco mes in HI V - infected prisoners: a 13 year retrospective evaluation R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 1 0 % Direct c osts per year: $34,390.00 T otal c osts f or pr oject p eri o d: $ 3 4, 3 9 0. 0 0 Pr oj ect p eri o d: 12/1/2011 - 11/30/2012

Pending Grants Age ncy: NI M H I. D. #: R01 MH121991 Titl e: Identifying Modifiable Risk and Protective Processes at the Day -L e v el t h at Predict HIV Care Outco mes a mong Wo men Exposed to Partner Violence P.I. : S ulli v a n, T a mi R ol e: Pri nci pal I nvestigat or P erce nt eff ort: 3 0 % Direct c osts per year: $499,755.00 T otal c osts f or pr oject p eri o d: $4,148,823.00 Pr oj ect p eri o d: 1/1/2020 - 12/31/2024

Invited Speaking Engage ments, Presentations, Sy mposia & Workshops Not Affiliated With Y al e: International/ National 2 0 1 9: C ME Outfitters, Washington, DC. " A Grassroots Approach to Weed out HI V and HC V in Special O U D Populations" 2 0 1 9: U S C o m missi o n o n Ci vil Ri g hts, W as hi n gt o n, D C. " A n A n al ysis of W o m e n’s H e alt h, P ers o n al Dignity and Sexual Abuse in the US Prison Syste m" 2 0 1 8: College of Proble ms on Drug Dependence, College of Proble ms on Drug Dependence, San Diego, CA. "Research on Wo men who Use Drugs: K no wledge and I mple mentation Gaps and A Proposed Research Agenda" 2 0 1 8: Clinical Care Options, Washington, DC. "Intersection of the HI V and Opioid Epide mics" 2 0 1 6: Dart mouth Geisel School of Medicine, Hanover, N H. "Incarceration as Opportunity: Prisoner H ealth and Health Interventions" 2 0 1 0: Rhode Island Chapter of the Association of Nurses in AI DS Care, Providence, RI. " HI V and A d dicti o n"

4 J ai mi e M e y er, M D, M S, F A C P

R e gi o n al 2 0 1 8: Clinical Directors Net work, Ne w York, NY. "PrEP A wareness a mong Special Populations of Wo men and People who Use Drugs" 2 0 1 8: Frank H. Netter School of Medicine, Quinnipiac University, Ha mden, CT. " HI V prevention for j ustic e -involved wo men" 2 0 1 7: Cl inical Directors Net work, Ne w York, NY. " Opti mizing the HI V Care Continuu m for People who use Drugs" 2 0 1 6: Fr a n k H. N ett er Sc h o ol of M e dici n e, Q ui n ni pi ac U ni v ersit y, H a m d e n, C T. " T o pics i n I nf ecti o us Diseases" 2 0 1 6: Connecticut Advanced Practice Register e d N urs e S oci et y, W et h ersfi el d, C T. " Tr e n ds i n HI V Prevention: Integration of Bio medical and Behavioral Approaches"

P e er -Revie wed Presentations & Sy mposia Given at Meetings Not Affiliated With Yale: International/ National 2 0 1 9: CP D D 81st Annual Scienti fic Meeting, CP D D, San Antonio, TX. "Punitive approaches to pregnant wo men with opioid use disorder: I mpact on health care utilization, outco mes and ethical i mplications" 2 0 1 9: 14th International Conference on HIV Treat ment and Prevention Adherence, I APAC Adherence, Mi a mi, FL. " D ecisi o n -Making about HIV Prevention a mong Wo men in Drug Treat ment: Is PrEP Contextually Relevant?" 2 0 1 9: 2019 NI D A International Foru m, NI D A, San Antonio, TX. " Diphenhydra mine Injection in Kyrgyz Pris o ns: A Q u alit ati v e St u d y Of A Hi g h -Risk Behavior With I mplications For Har m Reduction" 2 0 1 9: 11th International Wo men’s and Children’s Health and Gender (In Wo men’s) Group, In Wo men’s Group, San Antonio, TX. " Uniquely successful i mple mentation of methadone treat ment in a w o m e n’s pris o n in Kyrgyzstan" 2 0 1 9: Har m Reduction International, Porto, Porto District, Portugal. " Ho w does methadone treat ment travel? On the ‘beco ming -methadone -body’ of Kyrgyzstan prisons" 2 0 1 9: AP A Collaborative Perspectives on Addiction Annual Meeting, AP A Collaborative Perspect i v es on Addiction Annual Meeting, Providence, RI. "I mpact of Trau ma and Substance Abuse on HIV PrEP Outco mes a mong Wo men in Cri minal Justice Syste ms. Sy mposiu m: “Partner Violence: Intersected with or Predictive of Substance Use and Health Proble ms a mong Wo m e n.”" 2 0 1 9: Society for Acade mic E mergency Medicine (S AE M), Worcester, M A. "Effects of a Multisite Medical Ho me Intervention on E mergency Depart ment Use a mong Unstably Housed People with Hu man I m munodeficiency Virus" 2 0 1 9: Conference on Retroviruses and O p p ort u nistic I nf ecti o ns ( C R OI), I A S, S e attl e, W A. " R el e as e d t o Die: Elevated Mortality in People with HI V after Incarceration" 2 0 1 9: 12th Acade mic and Health Policy on Conference on Correctional Health, 12th Acade mic and Health Policy on Conference on C orr ecti o n al H e alt h, L as V e g as, N V. " Pr E P Eli gi bilit y a n d HI V Ris k Perception for Wo men across the Cri minal Justice Continuu m in Connecticut" 2 0 1 9: Ass ociati o n f or J ustice -Involved Fe male Organizations ( AJF O), Atlanta, G A. "Treat ment of Wo men’s Substance U se Disorders and HI V Prevention During and Follo wing Incarceration"

5 J ai mi e M e y er, M D, M S, F A C P

2 0 1 8: A merican Public Health Association ( AP H A) Annual Meeting, A merican Public Health Association ( AP H A) Annual Meeting, San Diego, C A. " Ne w Haven Syringe Service Progra m: A m o d el of i nt egrated har m reduction and health care services" 2 0 1 8: 12th National Har m Reduction Conference, 12th National Har m Reduction Conference, Ne w Orleans, L A. "Service needs and access to care a mong participants in the Ne w Haven Syringe Services Progra m" 2018 : 22nd International AI DS Conference, 22nd International AI DS Conference, A msterda m, N H, Netherlands. " HI V risk perceptions and risk reduction strategies a mong prisoners in Kyrgyzstan: a q ualitative st u dy" 2 0 1 8: 22nd International AI DS Conference, 22nd In ternational AI DS Conference, A msterda m, N H, Netherlands. " Methadone Maintenance Therapy Uptake, Retention, and Linkage for People who Inject Drugs Transitioning Fro m Prison to the Co m munity in Kyrgyzstan: Evaluation of a National Progra m" 2 0 1 8: NI D A I nt er n ati o n al F or u m, NI D A, S a n Di e g o, C A. " HI V a n d Dr u g Us e a m o n g W o m e n i n Pris o n i n Azerbaijan, Kyrgyzstan and Ukraine" 2 0 1 8: 2018 Conference on Retroviruses and Opportunistic Infections (CR OI), CR OI, Boston, M A. "Fro m pris o n’s gate t o deat h’s do or: S urvival analysis of released prisoners with HI V" 2 0 1 8: 11th Acade mic and Health Policy on Conference on Correctional Health, Acade mic Consortiu m on Cri minal Justice Health, Houston, TX. " Assessing Concurrent Validity of Cri minogenic and Health Risk Instru ments a m ong Wo men on Probation in Connecticut" 2 0 1 7: I D Week: Annual Meeting of Infectious Diseases Society of A merica, Infectious Diseases Society of A merica, San Diego, C A. "Predictors of Linkage to and Retention in HI V Care Follo wing Release fro m Connecticut, U S A Jails and Priso ns ( Oral presentatio n)" 2 0 1 7: I nt er n ati o n al AI D S S oci et y (I A S) M e eti n g, I nt er n ati o n al AI D S S oci et y, P aris, Îl e -d e -Fr a nc e, France. "Late breaker: Predictors of Linkage to and Retention in HI V Care Follo wing Release fro m Connecticut, US A Jails and Prisons" 2 0 1 7: NI D A I nt er n ati o n al Foru m, NI D A, Montreal, QC, Canada. " A Mixed Methods Evaluation of HIV Risk a mong Wo men with Opioid Dependence in Ukraine" 2 0 1 7: International Wo men's and Children's Health and Gender Working Group, International Wo men's and Children's Health and Gender W orking Group, Montreal, QC, Canada. " Assessing R ec e pti v e n ess t o a n d Eli gi bilit y f or Pr E P i n Cri mi n al J ustic e -Involved Wo men" 2 0 1 7: International Wo men's and Children's Health and Gender Working Group, International Wo men's and Children's Health and Gender Working Group, Montreal, QC, Canada. " A Mixed Methods Evaluation of HIV Risk a mong Wo men with Opioid Dependence in Ukraine" 2 0 1 7: Annual Meeting of the Society for Applied Anthropology, Society for Applied Anthropology, Santa Fe, N M. " Where rubbers meet the road: HI V risk reduction for wo men on probation ( Oral presentation)" 2 0 1 6: International Wo men's and Children's Health and Gender Working Group, International Wo men's and Children's Health and Gender Working Group, Pal m Springs, C A. "An Event -l e v el E x a mination of Successful Condo m Negotiation Strategies a mong College Wo men" 2 0 1 5: C DC National HIV Prevention Conference, C DC, Atlanta, G A. "Beyond the Synde mic: Condo m Negotiation and Use a mong Wo men Experiencing Partner Violence ( Oral presentation)"

6 J ai mi e M e y er, M D, M S, F A C P

2 0 1 5: International Har m Reduction Conference, International Har m Reduction, Kuala Lu mpur, Federal Territory of Kuala Lu mpur, Malaysia. "Evidence -Based Interventions to Enhance Assess ment, Treat ment, and Adherence in the Chronic Hepatitis C Care Continuu m" 2 0 1 5: International Wo men's and Children's Health and Gender Working Group, International Wo men's and Children's Health and Gender Working Group, Phoenix, AZ. " Violence, Substance Use, and Sexual Risk a mong College Wo men" 2 0 1 4: International Wo men's and Ch ildren's Health and Gender Working Group, International Wo men's and Children's Health and Gender Working Group, San Juan, San Juan, Puerto Rico. " Gender Differences in HI V and Cri minal Justice Outco mes" 2 0 1 4: College on Proble ms in Drug Dependence (CP D D), College on Proble ms in Drug Dependence (CP D D), San Juan, San Juan, Puerto Rico. " Gender Differences in HI V and Cri minal Justice Outco mes" 2 0 1 4: Conference on Retroviruses and Opportunistic Infections (CR OI), Conference on Retroviruses and Opportunistic I nfections (CR OI), Boston, M A. "Longitudinal Treat ment Outco mes in HI V - Infected Prisoners and Influence of Re -Incarceration" 2 0 1 3: HIV Intervention and I mple mentation Science Meeting, HIV Intervention and I mple mentation Science Meeting, Bethesda, M D. " Wo me n Released fro m Jail Experience Subopti mal HI V Treat ment Outco mes Co mpared to Men: Results fro m a Multi -Center Study" 2 0 1 3: Conference on Retroviruses and Opportunistic Infections (CR OI), Conference on Retroviruses and Opportunistic Infections ( C R OI), Atl anta, G A. " Wo men Released fro m Jail Experience Subopti mal HIV Treat ment Outco mes Co mpared to Men: Results fro m a Multi -Center Study" 2 0 1 2: I D Week: Infectious Diseases Society of A merica Annual Meeting, Infectious Diseases Society of A merica, San Diego, C A. " Correlates of Retention in HI V Care after Release fro m Jail: Results fr o m a M ulti -site St u dy" 2 0 1 2: I D Week: Infectious Diseases So ciety of A merica Annual Meeting, Infectious Diseases Society of A merica, San Diego, C A. "Frequent E mergency Depart ment Use a mong Released Prisoners with HI V: Characterization Including a Novel Multi morbidity Index" 2 0 1 2: 5th Acade mic and Health Policy Con ference on Correctional Health, 5th Acade mic and Health Policy Conference on Correctional Health, Atlanta, G A. "Effects of Inti mate Partner Violence on HI V and Substance Abuse in Released Jail Detainees" 2 0 1 1: IAPAC HIV Treat ment and Adherence Conference, I A P A C, Mi a mi, FL. " A d h er e nc e t o HI V treat ment and care a mong previously ho meless jail detainees"

R e gi o n al 2 0 1 9: Connecticut Infectious Disease Society, Ne w Haven, CT. "Preli minary Findings fro m a Novel PrEP De monstration Project for Wo men Involved in C ri minal Justice Syste ms and Me mbers of their Risk Net works" 2 0 1 7: Connecticut Public Health Association Annual Conference, Connecticut Public Health Association, Far mington, CT. "The Ne w Haven syringe services progra m" 2 0 1 4: Connecticut Infectious Diseas e Society Annual Meeting, Connecticut Infectious Disease Society, Orange, CT. "Longitudinal Treat ment Outco mes in HI V -Infected Prisoners and Influence of Re - Incarceration"

7 J ai mi e M e y er, M D, M S, F A C P

2 0 1 3: Connecticut Infectious Disease Society Annual Meeting, Connecticut Infectious Dis e as e S oci et y, Orange, CT. " Wo men Released fro m Jail Experience Subopti mal HIV Treat ment Outco mes Co mpared to Men: Results fro m a Multi -Center Study" 2 0 1 1: Connecticut Infectious Disease Society Annual Meeting, Connecticut Infectious Disease Society, O range, CT. "E mergency Depart ment Use by Released Prisoners with HIV"

Pr of essi o n al S er vic e: Peer Revie w Groups/ Grant Study Sections 2 0 1 9 - prese nt R e vi e w er, NI D A, NI H R e vi e w er: R F A -D A -1 9 -0 2 5: H E AL I niti ati v e: J ustic e C o m m u nit y Opioid Innovation Net work (JC OI N) Clinical Research Centers 2 0 1 9 - prese nt Revie wer, Yale DCF AR Pilot Projects 2 0 1 8 - prese nt Revie wer, Ce nter for I nter disci pl inary Research on AI DS (CIR A) 2 0 1 5 - prese nt Revie wer, University of Wisconsin -Mil waukee Research Gro wth Initiative

Advisory Boards 2017 Advisor, HI V Prevention and Treat ment in Cis -Gendered Wo men, Gilead Sciences, Inc.

J our nal Service E dit or/ Ass oci ate E dit or 2 0 1 9 - prese nt Associate Editor, Journal of the International Association of Providers of AI DS Care (JI AP AC), Section Editor: Sex and Gender Issues

Revie wer 2 0 1 9 - prese nt R e vi e w er, J AI D S 2 0 1 2 - prese nt R e vi e w er, A d dicti o n Sci a n d Cli n Pr act 2 0 1 2 - prese nt Revie wer, Addictive Behav Reports 2 0 1 2 - prese nt Revie wer, AI DS Care 2 0 1 2 - prese nt Revie wer, Social Science and Medicine 2 0 1 2 - prese nt Revie wer, SpringerPlus 2 0 1 2 - prese nt Revie we r, Substance Abuse Treat ment Prevention and Policy 2 0 1 2 - prese nt Revie wer, Wo men’s Health Issues 2 0 1 2 - prese nt Revie wer, Yale Journal of Biology and Medicine 2 0 1 2 - prese nt R e vi e w er, AI M S P u blic H e alt h 2 0 1 2 - prese nt Revie wer, A merican Journal on Add icti o ns 2 0 1 2 - prese nt Revie wer, A merican Journal of Epide miology 2 0 1 2 - prese nt Revie wer, A merican Journal of Public Health 2 0 1 2 - prese nt Revie wer, Annals Internal Medicine 2 0 1 2 - prese nt Revie wer, B MC E mergency Medicine 2 0 1 2 - prese nt Revie wer, B MC Infectious Diseases 2 0 1 2 - prese nt R e vi e w er, B M C P u blic H e alt h 2 0 1 2 - prese nt Revie wer, B MC Wo men’s Health

8 J ai mi e M e y er, M D, M S, F A C P

2 0 1 2 - prese nt R e vi e w er, Cli nic al I nf ecti o us Dis e as es 2 0 1 2 - prese nt R e vi e w er, Critic al P u blic H e alt h 2 0 1 2 - prese n t Revie wer, Drug and Alcohol Dependence 2 0 1 2 - prese nt Revie wer, Drug and Alcohol Revie w 2 0 1 2 - prese nt Revie wer, Epide miologic Revie ws 2 0 1 2 - prese nt Revie wer, Eurosurveillance 2 0 1 2 - prese nt Revie wer, Health and Justice (Springer Open) 2 0 1 2 - prese n t Revie wer, International Journal of Drug Policy 2 0 1 2 - prese nt Revie wer, International Journal of Prisoner Health 2 0 1 2 - prese nt Revie wer, International Journal of ST Ds and AI DS 2 0 1 2 - prese nt Revie wer, International Journal of Wo men’s Health 2 0 1 2 - prese nt Revie wer, J A M A Internal Medicine 2 0 1 2 - prese nt R e vi e w er, J o ur n al of F a mil y Vi ol e nc e 2 0 1 2 - prese nt Revie wer, Journal of General Internal Medicine 2 0 1 2 - prese nt Revie wer, Journal of I m migrant and Minority Health 2 0 1 2 - prese nt R e vi e w er, Journal of International AI DS Society 2 0 1 2 - prese nt Revie wer, Journal of Psychoactive Drugs 2 0 1 2 - prese nt Revie wer, Journal of Urban Health 2 0 1 2 - prese nt Revie wer, Journal of Wo men’s Health 2 0 1 2 - prese nt Revie wer, Open Foru m Infectious Diseases 2 0 1 2 - prese nt Revie wer, PLoS O NE 2 0 1 2 - prese nt Revie wer, Public Health Reports

Professional Service for Professional Organizations AA MC Group on Wo men in Medicine and Science ( G WI MS) 2 0 1 6 - prese nt Me mber, AA MC Group on Wo men in Medicine and Science ( G WI MS)

A merican College of Physicians 2 0 1 6 - prese nt F ell o w, A m eric a n C oll e g e of P h ysici a ns 2 0 1 3 - 2016 Me mber, A merican College of Physicians

A merican Medical Association 2 0 0 5 - pr es e nt Me mber, A merican Medical Association

A merican Medical Wo men’s Association 2 0 1 1 - prese nt Me mber, A merican Medical Wo men’s Association

A merican Society of Addiction Medicine 2 0 0 9 - prese nt Me mber, A merican Society of Addiction Medicine

9 J ai mi e M e y er, M D, M S, F A C P

Connect icut Infectious Disease Society 2 0 1 1 - prese nt Me mber, Connecticut Infectious Disease Society

Infectious Disease Society of A merica 2 0 0 8 - prese nt Me mber, Infectious Disease Society of A merica

In Wo men’s Net work, NI DA International Progra m 2 0 1 3 - prese nt Me mber, In Wo men’s Net work, NI DA International Progra m

Ne w York State Medical Society 2 0 0 5 - 2008 Me mber, Ne w York State Medical Society

Yale U niversity Service University Co m mittees 2 0 1 6 - 2018 Council Me mber, Leadership Council, Wo men’s Faculty Foru m

Medical School Co m mittees 2 0 1 5 - 2016 Co m mittee Me mber, US Health and Justice Course, Yale School of Medicine 2 0 1 4 - prese nt Co m mittee Me mber, Yale Internal Medicine Traditional Residency Intern Selection Co m mittee

P u blic S er vic e 2 0 1 9 - prese nt Faculty Me mber, Yale University P rogra m in Addiction Medicine 2 0 1 7 - prese nt Faculty Me mber, Arthur Li man Center for Public Interest La w, Yale La w School 2 0 1 3 - prese nt Mentor, Wo men in Medicine at Yale Mentoring Progra m 2 0 1 2 - prese nt Faculty Me mber, Yale Center for Interdisciplinary Research on AI DS 2 0 0 9 - 2011 Instructor, Preclinical Clerkship Tutor, Yale School of Medicine 2002 Fello w, Soros Open Society Institute 1 9 9 8 - 1999 Fello w, Costa Rican Hu manitarian Foundation

Bi bli o gr a p h y: P e er -Revie wed Original Research 1. Mey er J P , Qiu J, Chen NE, Larkin GL, Altice FL. E mergency depart ment use by released prisoners wit h HI V: a n o bs er v ati o n al l o n git u di n al st u d y. Pl o S O n e 2 0 1 2, 7: e 4 2 4 1 6. 2. C h e n N E, Mey er J P , B olli n g er R, P a g e K R. HI V t esti n g b e h a vi ors a m o n g L ati n os i n B alti m or e Cit y. Journal Of I m migrant And Minority Health / Center For Minority Public Health 2012, 14:540 -5 1. 3. C hits az E, Mey er J P , Kris h n a n A, S pri n g er S A, M arc us R, Z all er N, J or d a n A O, Li nc ol n T, Fl a ni g a n T P, P ort erfi el d J, Altic e FL. Contribution of substance use disorders on HI V treat ment outco mes and antiretroviral medication adherence a mong HIV -infected persons entering jail. AI DS And Behavior 2 0 1 3, 1 7 S u p pl 2: S 1 1 8 -2 7.

1 0 J ai mi e M e y er, M D, M S, F A C P

4. C h e n N E, Mey er J P , A v er y A K, Dr ai n e J, Fl a ni g a n T P, Li nc ol n T, S p a ul di n g A C, S pri n g er S A, Altic e FL. Adherence to HI V treat ment and care a mong previously ho meless jail detainees. AI DS And Behavior 2013, 17:2654 -6 6. 5. Alt h off AL, Z el e n e v A, Meyer J P , Fu J, Bro wn SE, Vagenas P, Avery AK, Cruzado -Q ui ñ o n es J, S p a ul di n g A C, Altic e FL. C orr el at es of r et e nti o n i n HI V c ar e aft er r el e as e fr o m j ail: r es ults fr o m a m ulti -site study. AI DS And Behavior 2013, 17 Suppl 2:S156 -7 0. 6. Willi a ms C T, Ki m S, M ey er J , S p a ul di n g A, T eix eir a P, A v er y A, M o or e K, Altic e F, M ur p h y -S w all o w D, Si m on D, Wickersha m J, Ouellet LJ. Gender differences in baseline health, needs at release, and predictors of care engage ment a mong HIV -p ositi v e cli e nts l e a vi n g j ail. AI D S A n d B e h a vi or 2 0 1 3, 1 7 S u p pl 2: S 1 9 5 -2 0 2. 7. Mey er J P , Wic k ers h a m J A, F u JJ, Br o w n S E, S ulli v a n T P, S pri n g er S A, Altic e FL. P art n er vi ol e nc e a n d health a mong HIV -infected jail detainees. International Journal Of Prisoner Health 2013, 9:124 -4 1. 8. Mey er J P , Qiu J, Chen NE, Larkin GL, Altice FL. Frequent e mergency depart ment use a mong released prisone rs with hu man i m munodeficiency virus: characterization including a novel multi morbidity index. Acade mic E mergency Medicine : Official Journal Of The Society For Acade mic E mergency Medicine 2013, 20:79 -8 8. 9. Mey er J P , Cepeda J, Springer S A, Wu J, Trest man RL, Altic e FL. HI V i n p e o pl e r ei nc arc er at e d i n Connecticut prisons and jails: an observational cohort study. The Lancet. HI V 2014, 1:e77 -e 8 4. 1 0. Mey er J P , Z el e n e v A, Wic k ers h a m J A, Willi a ms C T, T eix eir a P A, Altic e FL. G e n d er dis p ariti es i n HI V treat ment outco mes follo wing release fro m jail: results fro m a multicenter study. A merican Journal Of P u blic H e alt h 2 0 1 4, 1 0 4: 4 3 4 -4 1. 1 1. Mey er J P , C e p e d a J, W u J, Tr est m a n RL, Altic e FL, S pri n g er S A. O pti miz ati o n of h u m a n i m munodeficiency virus treat ment during incarceration: viral suppression at the prison gate. J A M A Internal Medicine 2014, 174:721 -9. 1 2. Mey er J P , C e p e d a J, T a x m a n F S, Altic e FL. S e x -R el at e d Dis p ariti es i n Cri mi n al J ustic e a n d HI V Treat ment Outco mes: A Retrospective Cohort Study of HIV -Infected In mates. A merican J o ur n al Of Public Health 2015, 105:1901 -1 0. 1 3. B o y d A T, S o n g DL, Mey er J P , Altice FL. E mergency depart ment use a mong HIV -i nf ect e d r el e as e d j ail detainees. Journal Of Urban Health : Bulletin Of The Ne w York Acade my Of Medicine 2015, 92:108 - 3 5. 1 4. S hrest ha R, Karki P, Altic e FL, H u e d o -M e di n a T B, Mey er J P , Madden L, Copenhaver M. Correlates of willi n g n ess t o i niti at e pr e -exposure prophylaxis and anticipation of practicing safer drug - a n d sex - related behaviors a mong high -risk drug users on methadone treat ment. Drug An d Alc o h ol Dependence 2017, 173:107 -1 1 6. 1 5. P e as a nt C, S ulli v a n T P, W eiss N H, M arti n ez I, Mey er J P . Beyond the synde mic: condo m negotiation and use a mong wo men experiencing partner violence. AI DS Care 2017, 29:516 -5 2 3. 1 6. Wic k ers h a m J A, Gi bs o n B A, B az azi A R, Pill ai V, P e d ers e n CJ, Mey er J P , El -B ass el N, M a y er K H, Ka marulza man A, Altice FL. Prevalence of Hu man I m munodeficiency Virus and Sexually Trans mitted Infections A mong Cisgender and Transgender Wo men Sex Workers in Greater Kuala Lu mpur, Malaysia: Results Fro m a Respondent -Driven Sa mpling Study. Sexually Trans mitted Diseases 2017, 44:663 -6 7 0. 1 7. H off E, M arc us R, B oj k o MJ, M a k ar e n k o I, M az h n a y a A, Altic e FL, Mey er J P . T h e eff ects of o pi oi d - agonist treat ments on HI V risk and social stability: A mixed methods study o f w o m e n wit h o pi oi d use disorder in Ukraine. Journal Of Substance Abuse Treat ment 2017, 83:36 -4 4.

1 1 J ai mi e M e y er, M D, M S, F A C P

1 8. R utl e d g e R, M a d d e n L, O g b u a g u O, Mey er J P . HI V Ris k p erc e pti o n a n d eli gi bilit y f or pr e -ex posure pr o p h yl a xis i n w o m e n i n v ol v e d i n t h e cri mi n al j ustic e s yst e m. AI DS Care 2018, 30:1282 -1 2 8 9. 1 9. P e as a nt C, S ulli v a n T P, Ritc h w o o d T D, P arr a G R, W eiss N H, Mey er J P , Murphy J G. Words can hurt: The effects of physical and psychological partner violence on condo m negotiation and condo m use a mong young wo men. Wo men & Health 2 0 1 8, 5 8: 4 8 3 -4 9 7. 2 0. L o eli g er K B, Altic e FL, D es ai M M, Ci arl e gli o M M, G all a g h er C, Mey er J P . Pr e dict ors of li n k a g e t o HI V care and viral suppression after release fro m jails and prisons: a retrospective cohort study. The L a nc et. HI V 2 0 1 8, 5: e 9 6 -e 1 0 6. 2 1. O di o C D, C arr oll M, Gl ass S, B a u m a n A, T a x m a n F S, Mey er J P . Eval uati ng c o nc urrent vali dity of cri minal justice and clinical assess ments a mong wo men on probation. Health & Justice 2018, 6:7. 2 2. L o eli g er K B, Altic e FL, Ci arl e gli o M M, Ric h K M, C h a n dr a D K, G all a g h er C, D e s ai M M, Mey er J P . All - cause mortality a mong people with HI V released fro m an integrated syste m of jails and prisons in Connecticut, US A, 2007 -14: a retrospective observational cohort study. The Lancet. HI V 2018, 5: e 6 1 7 -e 6 2 8. 2 3. L o eli g er K B, Mey er J P , D es ai M M , Ci arl e gli o M M, G all a g h er C, Altic e FL. R et e nti o n i n HI V c ar e during the 3 years follo wing release fro m incarceration: A cohort study. PLoS Medicine 2018, 15:e1002667. 2 4. Az b el L, W e g m a n M P, P ol o ns k y M, B ac hir e d d y C, M ey er J , Shu mskaya N, Kur manalieva A, Dvo r y a k S, Altic e FL. Dr u g i nj ecti o n wit hi n pris o n i n K yr g yzst a n: el e v at e d HI V ris k a n d i m plic ati o ns f or sc ali n g up opioid agonist treat ments. International Journal Of Prisoner Health 2018, 14:175 -1 8 7. 2 5. Peasant C, Montanaro E A, Kersha w TS, Parra GR, Weiss N H, Mey er J P , M ur p h y J G, Ritc h w o o d T D, S ulli v a n T P. A n e v e nt -level exa mination of successful condo m negotiation strategies a mong young wo men. Journal Of Health Psychology 2019, 24:898 -9 0 8. 2 6. R a njit Y S, Az b el L, Kris h n a n A, Altic e FL, Mey er J P . E v al u ati o n of HI V ris k a n d o utc o m es i n a nationally representative sa mple of incarcerated wo men in Azerbaijan, Kyrgyzstan, and Ukraine. AI DS Care 2019, 31:793 -7 9 7. 2 7. R h o d es T, Az b el L, L a nc ast er K, M ey er J . The beco ming -methadone -body: on the onto -p olitics of health intervention translations. Sociology Of Health & Illness 2019, 41:1618 -1 6 3 6. 2 8. Ols o n B, Vi nc e nt W, Mey er J P , Kersha w T, Sikke ma KJ, Heck man T G, Hansen NB. Depressive sy mpto ms, physical sy mpto ms, a n d h e alt h -r el at e d q u alit y of lif e a m o n g ol d er a d ults wit h HI V. Quality Of Life Research : An International Journal Of Quality Of Life Aspects Of Treat ment, Care A n d R e h a bilit ati o n 2 0 1 9.

Chapters, Books, and Revie ws 2 9. Az ar M M, S pri n g er S A, Mey er J P , Altic e FL. A syste matic revie w of the i mpact of alcohol use disorders on HI V treat ment outco mes, adherence to antiretroviral therapy and health care utilization. Drug And Alcohol Dependence 2010, 112:178 -9 3. 3 0. Mey er J P , Springer S A, Altice FL. Substance abuse, vio l e nc e, a n d HI V i n w o m e n: a lit er at ur e r e vi e w of the synde mic. Journal Of Wo men's Health (2002) 2011, 20:991 -1 0 0 6. 3 1. Mey er J P , Chen NE, Springer S A. HI V Treat ment in the Cri minal Justice Syste m: Critical Kno wledge and Intervention Gaps. AI DS Research And Trea t ment 2011, 2011:680617. 3 2. S pri n g er S A, S p a ul di n g A C, Mey er J P , Altic e FL. P u blic h e alt h i m plic ati o ns f or a d e q u at e tr a nsiti o n al c ar e f or HI V -infected prisoners: five esse ntial co m po nents. Clinical Infectio us Diseases : An Official P u blic ati o n Of T h e I nf ecti o us Diseases Society Of A merica 2011, 53:469 -7 9.

1 2 J ai mi e M e y er, M D, M S, F A C P

3 3. C h e n N E, Mey er J P , Springer S A. Advances in the prevention of heterosexual trans mission of HI V/ AI DS a mong wo men in the United States. Infectious Disease Reports 2011, 3. 3 4. M ey er J , Altic e F. HI V i n I nj ecti o n a nd Other Drug Users. So mesh Gupta, Bhushan Ku mar, eds. S e x u all y Tr a ns mitt e d I nf ecti o ns 2 n d e d. N e w D el hi, I n di a: Els e vi er, 2 0 1 2: 1 0 6 1 -8 0. I S B N 9 7 8 -8 1 - 3 1 2 -2809 -8. 3 5. Mey er J P , Alt h off AL, Altic e FL. O pti mizi n g c ar e f or HI V -infected people who use drugs: evid e nce - based approaches to overco ming healthcare disparities. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of A merica 2013, 57:1309 -1 7. 3 6. M ey er J , Altice F. Chapter 47, Treat ment of Addictions: Transition to the Co m m u nit y. R o b ert L. Trest man, Kenneth L. Appelbau m, Jeffrey L. Metzner, eds. Oxford Textbook of Correctional Psychiatry ( Winner of the 2016 Gutt macher A ward). Oxford University Press 2015. ISB N 9780199360574. 3 7. Mey er J P , M o g hi mi Y, M arc us R, Li m J K, Lit wi n A H, Altic e FL. E vi d e nc e -based interventio ns to enhance assess ment, treat ment, and adherence in the chronic Hepatitis C care continuu m. The International Journal On Drug Policy 2015, 26:922 -3 5. 3 8. M o h ar e b A, Ti b eri o P, M a n di mi k a C, M ut h uli n g a m D, M ey er J . I nfectious Diseases in Underserved Populations. Onye ma Ogbuagu, Gerald Friedland, Merceditas Villanueva, Marjorie Golden, eds. Current Diagnosis and Treat ment - Infectious Diseases. Mc Gra w -Hill M e dic al 2 0 1 6. 3 9. Mey er J P , Wo mack J A, Gibson B. Beyond the Pap S mear: Gender -responsive HIV Care for Wo men. The Yale Journal Of Biology And Medicine 2016, 89:193 -2 0 3. 4 0. Mey er J P , M ut h uli n g a m D, El -B ass el N, Altic e FL. L e v er a gi n g t h e U. S. Cri mi n al J ustic e S yst e m t o Access Wo men for HIV Interventions. AI DS And Behavior 201 7, 2 1: 3 5 2 7 -3 5 4 8. 4 1. Shrestha R, McCoy -R e d d B, M ey er J . Pr e -Exposure Prophylaxis (PrEP) for People Who Inject Drugs ( P WI D). Bri a n n a N ort o n, E d. T h e O pi oi d E pi d e mic a n d I nf ecti o us Dis e as es. Els e vi er 2 0 1 9. 4 2. Mey er J P , Is a acs K, El -Shaha wy O, Burle w AK, Wechsbe rg W. Research on wo men with substance use disorders: Revie wing progress and developing a research and i mple mentation road map. Drug And Alcohol Dependence 2019, 197:158 -1 6 3.

P e er -Revie wed Educational Materials 4 3. The Fortune Society Reentry Education Proje ct D et aili n g Kit. N e w Y or k Cit y D e p art m e nt of H e alt h and Mental Hygiene. October 2014 4 4. United Nations Office on Drugs and Cri me. Vienna, Austria

Invited Editorials and Co m mentaries 4 5. Mey er J P . Capsule Co m mentary on Pyra et al., sexual minority status and violence a mong HI V infected and at -risk wo men. Journal Of General Internal Medicine 2014, 29:1164. 4 6. Bri n kl e y -R u bi nst ei n L, D a uri a E, T ol o u -Sha ms M, Christopoulos K, Chan P A, Beck with C G , P ar k er S, M ey er J . The Path to I mple mentation of HI V Pre -exposure Prophylaxis for People Involved in Cri minal Justice Syste ms. Current HI V/ AI DS Reports 2018, 15:93 -9 5. 4 7. Mey er J P . The Sustained Har mful Health Effects of Incarceration for Wo men Living with HI V. Journal Of Wo men's Health (2002) 2019, 28:1017 -1 0 1 8.

1 3 J ai mi e M e y er, M D, M S, F A C P

Case Reports, Technical Notes, Letters 4 8. P a ul J . Bullous pe mphigoid in a patient with psoriasis and possible drug reaction: a case report. Connecticut Medicine 2004, 68:611 -5. 4 9. H o w J, Az ar M M, Mey er J P . Are Nectarines to Bla me? A Case Report and Literature Revie w of Spontaneous Bacterial Peritonitis Due to Listeria monocytogenes. Connecticut Medicine 2015, 7 9: 3 1 -6. 5 0. V az q u ez G uill a m et LJ, M ali nis M F, Mey er J P . E merging role of Actino myces meyeri in bra i n abscesses: A case report and literature revie w. I DCases 2017, 10:26 -2 9. 5 1. H ar a d a K, H e at o n H, C h e n J, V az q u ez M, M ey er J . Zoster vacci ne -associate d pri mary varicella infection in an i m munoco mpetent host. B MJ Case Reports 2017, 2017. 5 2. Ber nar d o R, Streiter S , Ti b eri o P, R o d wi n B A, M o h ar e b A, O g b u a g u O, E m u B, Mey er J P . A ns w er t o Dece mber 2017 Photo Quiz. Journal Of Clinical Microbiology 2017, 55:3568. 5 3. B er n ar d o R, Str eit er S, Ti b eri o P, R o d wi n B A, M o h ar e b A, O g b u a g u O, E m u B, Mey er J P . P h ot o Q uiz: P eri p h er al B lood S mear in a Ugandan Refugee. Journal Of Clinical Microbiology 2017, 55:3313 - 3 3 1 4.

Sc h olars hi p I n Press 5 4. Hoff E, Ada ms Z, Dasgupta A, Goddard D, Sheth S, M ey er J . Reproductive Health Justice and Autono my: A syste matic revie w of pregnancy planning int entions, needs, and interventions a mong w o m e n i n v ol v e d i n U S cri mi n al j ustic e s yst e ms. J W o m e n’s H e alt h

1 4 Coronavirus C OVI D -1 9 a n d t h e C orr ecti o n al F acilit y

Updated for NCC HC Webinar, Pande mic Day 3

A n n e C. S p a ul di n g M D M P H March 13, 2020 E mory Center for the Health of Incarcerated Persons Aspauld @e mory.edu Please do not alter content without contacting author and collaborators

R O L LI N S E M O R Y S C H O O L O F P U B LI C H E A L T H P R E -TEST Ite m Response Y o ur P oi nts 1. Exchanged contact infor mation with local/state Yes a n d Yes: + 9 p oi nts health depart ment? Established a point of contact? Will c o nt act t h e m t o d a y: + 1 p oi nt N o: s u btract 1 2. D o es y o ur f acilit y h a v e pl a ns i n pl ac e t o s e n d ill st aff Yes : + 1 p oi nt (both public sector, contractors) ho me/to hospital? N o: s u btract 1 3. Screening folks entering your custody for exposure ? Yes a n d Yes : + 2 Cough, OR shortness of breath, OR te mp. > 100.4 F? Yes or Yes: + 1 N o: s u btract 1 4. Ar e y o u ( or will y o u b e) s e p ar ati n g sic k (is ol ati o n) Yes: + 1 p oi nts fro m exposed (quarantined) fro m general population? N o: s u btract 1

Total: ______3. 1 3. 2 0 2 0 ( o ut of p ossi ble t otal of 13) O utli n e: C O VI D -1 9 Overvie w for a Congregate Environ ment 1. Spread 2. Pr e v e nti o n: Actions taken to prevent the spread of virus within a facility that include hand washing, environ mental cleaning, and social distancing bet ween well 3. Sy mpto ms, Diagnosis and Treat ment 4. Facility Manage ment B OP signage • Is ol ati o n — procedure of se p ar ati n g t h e alr e a d y sic k H e alt h Al e n! fr o m t h os e n ot ill, t o prevent the spread of disease. J A/ e n a d B s at u dt

T h e t er m is ol ati o n is disti nct fr o m t h e t er m C o u g hi n g spreads g er m s. q u ar a nti n e. Pr ot e ct y o urs elf a n d ot h er s. Al t os er s e trans miten mi cr o bi o s. • Quarantine — procedure of separating and Pr ot ej a s e U d. y a l o s d e m o s. C o v er y o ur c o u g h. restricting the move ment of persons n ot sic k Tapese l a b oc a al t o s er. y et, b ut w er e ex p os e d. All o ws r a pi d

If y o u ar e c o u g hi n g, a s k a b o ut a f a c e identification of those who b ec o m e sic k. m a s k t o w e ar i n H e alt h S er vi c e s. Si u st e d e st a t asi e n d o, pi d a al p ers o n al d e • Other i mplications for corrections . S er vi ci o s M e di c os u n a mascara p ar a c u brirs e. Cl e a n h a n d s oft e n. L6vese l a s m o n os c o n fr ec u e nci a.

3. 1 3. 2 0 2 0 C O VI D- 19 Overvie w: Spread • C O VI D - 1 9 is a vir al dis e as e • T h e vir us’ offici al n a m e is “ S A R S- C o V -2”; C O VI D -19 is the na me of the disease • Tr a ns missi o n • T h e virus is thought to spread mainly fro m person -t o -pers o n . I nc u b ati o n p eri o d: 2 -1 4 d a ys. • Bet ween people who are in close contact with one another ( within about 6 feet) • Via respiratory droplets produced when an infected person coughs or sneezes. • Dr o plets ca n l a n d i n mouths/eyes/noses of p e o pl e near by or p ossi bl y b e i n h al e d i nt o l u n gs. • May spread fro m inani mate objects that have virus on the m, b ut t his is n ot t h e m ai n w a y it s pr e a ds. • People are thought to be most contagious when they are t h e sic k est. • So me spread might be possible before people sho w sy mpto ms, b ut t his is n ot t h e m ai n w a y it s pr e a ds.

3. 1 3. 2 0 2 0 C O VI D- 19 Overvie w: Spread • C O VI D - 1 9 is a vir al dis e as e • T h e vir us’ offici al n a m e is “ S A R S- C o V -2”; C O VI D -19 is the na me of the disease • Tr a ns missi o n • T h e virus is thought to spread mainly fro m person -t o -pers o n. • Bet ween people who are in close contact with one another ( within about 6 feet) • Via respiratory droplets produced when an infected person coughs or sneezes. • Dr o plets ca n l a n d i n m o ut hs or n oses of pe o ple near by or p ossi bl y b e i n h al e d i nt o l u n gs. • May spread fro m inani mate objects that have virus on the m, b ut t his is n ot t h e m ai n w a y it s pr e a ds. • Sicker person: more contagious. • S o m e s prea d before people sho w sy mpto ms, b ut t his is n ot t h e m ai n w a y it s pr e a ds.

3. 1 3. 2 0 2 0 0 8 htt ps:// w w w .cdc.gov /coronavirus/2019-ncov/cases-in-us .ht ml l!Ili * C O VI D -1 9 O v er vi e w: ...., Spread • Fro m Wuhan to World wide. • Mi d - March 2020, several US hotspots. • K e e p u p wit h l oc al sit u ati o n. • If it’s spreading in your co m munity, it’s li k el y t o s h o w u p i n y o ur l oc al j ail or pris o n . Territ ories B 8 8 G 8 E) E J G

Re p orte d C as es

0 N o n e e 1 t o 5 6t o 1 0 • 1 1 t o 2 0 • 2 1 t o 5 0 • 5 1 t o 1 0 0 • 1 0 1 to200 • 2 0 1 to500

Persons entering your correctional facilities could have been ex p os e d w hil e i n a hi g hl y pr e v al e nt r e gi o n, n e ar or f ar, or m a y h a v e b e e n i n cl os e pr oxi mit y t o just one case … 3. 1 3. 2 0 2 0 C O VI D- 1 9 O v er vi e w: Prevention • A v oi d close contact with people who are sick . No hugs, no handshakes. • Avoid touching your eyes, nose, and mouth. • Cover your cough or sneeze with a tissue, then thro w the tissue in the trash. • Wash your hands with soap and water frequently, esp. after cough. • Wash for 20 seconds —as long as it takes to sing the Happy Birthday song . • Cl e a n/ disi nf ect frequently touched o bjects/ s urfaces : h os pit al -gr a d e disi nf ect a nt. • F oll o w C DC’s reco m mendations for using face mask, isolation of infected persons. • C orr ecti o n al st aff s h o ul d st a y off fr o m w or k if t h e y f e el sic k. Have a cough, fever and/or shortness of breath? S t a y h o m e. If illness beco mes worse, seek medical care; call ahead before you go!

3. 1 3. 2 0 2 0 Overvie w : Sy mpto ms & Diagnosis

• Many people are asy mpto matic or only have mild sy mpto ms. fi 0,: V ~ g SY MPT O MS O F C OR ONAVIRUS DISEASE ~

• Can appear soon (~ 2 days) or long (~2 weeks) after exposure. Patie nts wit h C 0 VI D- 1 9 ha ve e x perie nce d mil d t o Average: 5 days. se vere res pirat or y ill ness. Sy mpto ms * ca n i ncl u de • So me co m mon sy mpto ms: fever, cough, shortness of breath. W hic h s o u n ds a n a wf ul l ot li k e t h e fl u …

See C DC.gov for up -t o -d at e signage you can copy • S e e k m e dic al a d vic e If y o u d e v el o p Ti p : fi nis h u p y o ur fl u v acci n e sy mpto ms , a n d h a v e b e e n I n cl o s e c o nt a ct wit h a p er s o n k n o w n t o h a v e C 0 VI D -1 9 or if y o u liv e I n or h a v e r e c e ntly b e e n I n a n ar e a wit h stock no w! o n g oi n g s pr e a d of C 0 VI D- 1 9.

F or m or e i nf o o nali o n : w w w. c c k. gft/ C O VI D 1 9- s, m pt o m s

3. 1 3. 2 0 2 0 Overvie w : Sy mpto ms & Diagnosis T o r e vi e w, t h e co m mon sy mpto ms are : 1) fever, 2) cough, and 3) shortness of breath . Diagn ostic guidelines, best tests are evolving, s o check your l ocal an d state health depart ment for latest updates. Also: go to C DC.gov 1. C HECK where patient has been within 14 days of the onset of sy mpto ms — -- A ny place o n c urre nt list of areas w h er e t h er e is l oc al trans mission?? 2. ASK about contact with an infected person. 3. A S S E S S S y m pt o ms — note fever may not be evident if taking fever suppressing medications. .

3. 1 3. 2 0 2 0 Al as k a D o e s t h e f>ers o n h e ve \,\'r 1l 1 1 1· tllf' l 1r t l · ~ : L 1•/ 1 1 1 1· tllf' 1:,·r· : 1· h·, 1• 1 1• 1 1 1· D O C s~pto ms of C O VI D- 1 9 ? 1i!li': t, ~l p, 1·: ~ 1. 1 1 q ~ 1 1: 1111•11 Fl o w C h art:

C o h ort as l ast r es ort.

O nly c o h ort sy mpto matic p ati e nts wit h *lab diagnosed* C O VI D t oget her. c o urt esy: R. La wrence

3. 1 3. 2 0 2 0 ------r .C >----- ~

Ol d 't h e p ers o n h ev e e n y c o n"t ect , v n t ~ e l a bc > n!lt ory- N e: >------Al as k a o o nr, rr n- «f c es e al O O VI D-: 1. 9

Di d t h e p er s o n ,...., v e c o nt e c:'t , v 1't h tt ~ e c ortf ol T Tl e- d c e s e. ,.,, ~ h o n 't h e c o nt e > et al lrvon & r .: C >- D O C ,. v,'l h. t > e'I,... 1nt1 me1.e , v rt. h. o r c er, n a, f o r. o p er s o n o o n t o1TT1ed O O Vl D-: 1. 9., Fl o w C h art ,.. 'II V es t h e p ers o n , n t h es e m e o nct o or e...., or o nr n e nt e s e confir med O O VI D-:1.9 r- . o c es e t or e, prolon &e m>

HI G H RI S K M E DI U M RI S K L O W RI S K N O I D E N TI FI E D RI S K H o us e i n si n gl e c ell. M o nit ori n g House si n gl e c ell. M o nit ori n g t o Acti o ns f or n o Pl ac e i n q u ar a nti n e. R e m ai n t o i ncl u d e V S wit h te mperature i ncl u d e V S bi d. W e ar m as k i n C O VI D -1 9 under quarantine authority. No None bi d. N o c o ngregate activities. congregate settings or when sy mpto ms acti viti es i n p u blic s etti n gs. Mask f or tra ns p ort o ut of c ell. m o vi n g wit hi n t h e f acilit y. I m m e di at e is ol ati o n; m e dic al I m m e di at e is ol ati o n; m e dic al e v al u ati o n p er P UI i nstr ucti o ns. H o us e i n si n gl e c ell. A v oi d R o uti n e wit h C O VI D -1 9 evaluation according to P UI Pr e -n otify h os pital/E R of a ny congregate activities. Wear mask c ar e sy mpto ms g ui d eli n es. M as k f or all tr a nsf ers. M as k f or all for any move ment outside cell. move ment outside cell. move ment outside is ol ati o n.

3. 1 3. 2 0 2 0 r. u-

Y E S Ol d 't h e p ers o n h ev e e n y o o n't e ct , vrt 1, e l e.l > c >,,..t or y------N O------Al as k a o o nf, r Tne-d c e ~ Oil O O Vt D-: 1. 9 "'-'rt h o n 1: h e l e s't : 1.. C D o cl "t h e p er s o n 1-... v e o o nt e c "t ..v , 't h tt, e d-- s . h a s 1: h e c orlf,rr n e d c e ~. ,v n. h , n 't h e c o n t e, ct. CII I r v in & p e r s c::, n b e-- e n 1n e n ------r. ::. >-- '\. V 1 'l h . b e'I,... , nt 1m. e 1. e, vrt h. or c er, n a, f o r . . e D O C e ff e c 1: e d & e- ocr- e p h , c p er s o n c o n t , rr n e d O O V'I D-: 1. 9., Fl o w er e e

C h art r- .

V\l e s t t ... e- pers o n , n t t ... e- s e f Tl e' in cl o e >r V V ~e e ll r-eco m mende-d e...., o n: > n.- n e.-. e s a o o nt,rr n e- d O O VI D-:1.9 N O pr ec a u-r. i o n s t or- ho me c e r e e n d c e ~ t or e pn: >lon &e,ct p erl O d b L. C di d n sa me- "\. v e•t •n• r<>e> m ,. S e.r T'l e clessroe> m>

3. 1 3. 2 0 2 0 C O VI D- 19, the ne w type of coronavirus For those not needing hospital transfer: • Treat ment • Rest; Drink fluids to prevent dehydration • Take medicine to reduce fever (for exa mple, aceta minophen) • Research is ongoing on the use of already -developed medications • Health care staff should be made a ware if patient worse sy mpto ms develop, e.g., S OB • Vacci nati o n • None yet for C O VI D- 1 9 as of mi d -2020; trials starti ng s o o n, res ults i n > 1+ year

3. 1 3. 2 0 2 0 C O VI D- 1 9 Ris ks: M a k e a List of M ost V ul n er a bl e

1. In anyone, C OVI D-19 can beco me serious or be fatal. C O VI D- 1 9 d e at h r at e b y a g e

D e at h r at e 2. Serious disease, death: most co m mon in older persons 1 5 % 14.8 %

and/or those with underlying medical conditions 1 2 %

3. Medical should make custody a ware of most vulnerable 9 % patie nts; n o nee d to discl ose the nature of their 8 % di a g n os es a n d vi ol at e HI P A A. 6 % 3. 6 % 3 % If do wnsizing of population needed, 1. 3 % 0. 2 % 0.2 % 0.2 % 0. 4 % I 0 - - - - then persons at high priority fro m 1 0- 1 9 2 0- 2 9 3 0- 3 9 4 0- 4 9 5• 0- 5 9 6 0- 6 9 7 0- 7 9 8 0 + healt h p oi nt of vie w targete d. A ge Source: China C DC T hi nk of y our patients i n c hronic care clinics, your pregnant patients a n d h o w y o u will k e e p t h e m s af e fr o m dis e as e.

3. 1 3. 2 0 2 0 I m plic ati o ns f or C orrecti o nal Healt h Staff 1. Healthcare staff should be a ware of ongoing updates to clinical guidelines. 2. Have your pande mic plan in place 3. S h ar e wit h y o ur l oc al h e alt h d e p art m e nt: r ol e of y o ur f acilit y i n pr e v e nti o n, identification, and manage ment of infectious disease. • Re mind the m that you are in their territory. S wap contact infor mation. • Just b/c you have a healthcare staff … ( which may be hired via a private vendor) …doesn’t mean that H D shouldn’t consider ho w the presence of a jail and prison, and move ment of folks in/out of the facility, i mpacts public health. And: Work with your facility on planning no w: where to cohort persons (placing persons diagnosed with coronavirus together, but at a distance fr o m f ol ks w h o ar e w ell) if m a n y p e o pl e ar e g etti n g sic k at t h e s a m e ti m e.

3. 1 3. 2 0 2 0 Health Services: Check for updates local health depart ment a n d htt ps :// w w w.cdc.gov/coronavirus / and regional/corporate infection control coordinators, if any) as needed for latest guidelines on:

1. Ho w to isolate persons — when is negative pressure roo m indicated? 2. Ho w long to quarantine those exposed, isolate those infected? 3. What personal protective equip ment needed, for who m: eye shield, N95/surgical mask, gloves, go wns? 4. Ho w to handle those exposed to case of C O VI D-19, especially after 1 st . test is negative: when to repeat before infection can be ruled out? 5. W h e n c a n is ol ati o n b e lift e d ?

no boot covers

3. 1 3. 2 0 2 0 Al as k a D O C L e v els of Quarantine : c o urt esy R. L a wr e nc e

L e v el Descri pti o n Sce nari o D et ails Q u ar a nti n e of a n ex p os e d i n di vi d u al t o i ncl u d e si n gl e E x p os e d i n di vi d u al is b o o k e d i nt o a c ell h o usi n g, i n -c ell m e als, r estricti o n of m o v e m e nt, a n d I I n di vi d u al l e v el D O C f acilit y separation fro m congregate activities for duration of incubation period. Q u ar a nti n e of all i n m at es i n a m o d ul e wit h r estricti o n of A n ill i n di vi d u al is i d e ntifi e d i n a m o v e m e nt t o wit hi n t h e m o d ul e, i n - m o d ul e m e als, II M o d ul e l e v el si n gl e m o d ul e separation fro m congregate activities outside the module for the duration of the incubation period. M ulti pl e ill i n di vi d u als ar e Q u ar a nti n e of all i n m at es i n a n ex p os e d f acilit y t o III F acilit y l e v el identified in separate modules or include restriction of move ment to and fro m the facility ar e as for the duration of the incubation period. Quarantine of exposed in mates in multiple modules A n ill i n di vi d u al is i d e ntifi e d aft er wit hi n m ulti pl e f aciliti es wit h r estricti o n of m o v e m e nt I V I nt er -f acilit y l e v el move ment bet ween facilities to and fro m the facilities/ modules, and separation of d uring the infectious period exposed in mates fro m congregate activities.

3. 1 3. 2 0 2 0 Alaska D OC Levels of Quarantine

3. 1 3. 2 0 2 0 I m plic ati o ns f or Correctional Custody Staff

• Jurisdictions need to understand that incarceration of persons defying quarantine orders could lead to exponential increases in jail cases and c as es i n t h e c o m m u nit y. • Measures other than detention should be considered, such as at- ho me electronic monitoring. • Custody should plan on future absenteeis m of ill correctional offic ers. • Supply chains ( medicines, food, etc.) may beco me disrupted. • Consider alternatives to incarcerati on, in order to kee p stock population do wn (diversionary courts, co m munity corrections) . • If C O VI D -19 is in your jurisdiction, consider restriction of move ment in an d out (visitors, n on-esse ntial ve n d ors, tours).

3. 1 3. 2 0 2 0 Ot h er Iss u es for C orrecti o nal Healt hcare • Make sure persons confined in your facility have access to soap for han d washing; tissue for nasal discharge, etc. • Consider suspending co -pay for me dical visits t o eval uate s ore throat, cough, fever, shortness of breath. • Consider what will happen if health care workers sick and need to stay ho me, or ho me caring for others.

• Prepare for absenteeis m/discourage “presentis m”

3. 1 3. 2 0 2 0 P ost -test for C orrecti o ns

Q u esti o n: w h er e d o i n di vi d u als d w ell i n cl os e pr oxi mit y , sl e e p in cl ose q uarters, eat together, recreate in s mall spaces, with st aff cl os e b y ? A. J ails B. Cr uis e S hi ps C. Pris o ns D. A & C E. All of the above

3. 1 3. 2 0 2 0 Res ources: • https:// w w w.cdc.gov/coronavirus/2019 -ncov/index.ht ml Many correctional syste ms have developed pande mic flu plans. T h es e plans can be readily adapted to C O VI D- 19 and readapted as we learn more T h e B O P pl a n is a v ail a bl e o nli n e: • htt ps:// w w w.bop.gov/resources/pdfs/seasonal_influenza_guidance.pdf • Q uesti o ns? Aspauld @e mory.edu • E mory Center for the Health of Incarcerated Persons, Atlanta G A Ackno wledg ments: I a m grateful for constructive criticis m fro m Allis o n C h a m b erl ai n, N e wt o n K e n di g, A n k Nij h a w a n, Di a n n e Rechtine, Marc Stern, and countless colleagues who are govern ment e mployees. To check the C DC we bsites f or areas of c urre nt activity: I nt’l: htt ps:// w w w.cdc.gov/coronavirus/2019- ncov/travelers/index.ht ml U S: htt ps:// w w w.cdc.gov/coronavirus/2019- ncov/cases -i n -us. ht ml 3. 1 3. 2 0 2 0